# Levothyroxine Sodium

NDC: 70511-111
Generic name: LEVOTHYROXINE SODIUM ANHYDROUS
Labeler / Manufacturer: MAIA Pharmaceuticals, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Routes: INTRAVENOUS
Marketing started: 20181227

FDA application: ANDA208749

## Active ingredients

- LEVOTHYROXINE SODIUM ANHYDROUS: 100 ug/5mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"70511-111"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=70511-111
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=4e9adc35-3aba-4a0d-9c4e-7e7ee2ffdabd